{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:10:31Z","timestamp":1778767831193,"version":"3.51.4"},"reference-count":45,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Non-invasive prenatal testing (NIPT) examines cell-free DNA (cfDNA) in maternal serum, which includes both maternal DNA and apoptotic placental DNA. The presence of multiple aneuploidies or widespread abnormal patterns of gains and losses across chromosomes in a structurally normal fetus has been linked to maternal cancer. Case Presentation: The patient was a 22-year-old G1P0 with a history of classical Hodgkin\u2019s lymphoma in remission. Her NIPT collected at 14 weeks and 3 days was reported as a \u201cno call\u201d. A second NIPT at a different laboratory showed multiple chromosomal aneuploidies (trisomy 18, 21, and monosomy X) with normal fetal anatomy on ultrasound. The patient was asymptomatic and was referred to hematology\u2013oncology specifically to address the concern that these NIPT results could be related to cancer recurrence. Imaging was deferred as she was already on an established surveillance protocol for her Hodgkin\u2019s lymphoma. At 26 weeks of gestation, the patient presented with a cough and dyspnea. Chest x-ray raised concern for disease recurrence, and biopsy confirmed recurrent Hodgkin\u2019s lymphoma. She received two cycles of ICE chemotherapy. Cesarean delivery at 34 weeks and 2 days was performed for non-reassuring fetal heart tones. She continued chemotherapy, followed by BEAM conditioning and autologous stem cell transplantation. Genetic testing of the neonate revealed a normal karyotype; the placenta karyotype yielded no interpretable results. Discussion and Conclusions: Certain patterns of abnormal NIPT results may be associated with maternal malignancy and warrant further investigation. The absence of standardized protocols for reporting such NIPT results can complicate timely interdisciplinary evaluation and treatment. However, diagnostic testing should be offered with a positive NIPT result, a no-call or test failure, and abnormal ultrasound results, even with a \u201clow-risk\u201d NIPT result.<\/jats:p>","DOI":"10.3390\/diagnostics16101490","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:04:09Z","timestamp":1778763849000},"page":"1490","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Hodgkin\u2019s Lymphoma Detected Using Abnormal NIPT in Pregnancy: A Case Report and Literature Review"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5984-5635","authenticated-orcid":false,"given":"Claudia","family":"Szlek","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0488-6345","authenticated-orcid":false,"given":"Puja","family":"Punukollu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5086-4498","authenticated-orcid":false,"given":"Lindsey","family":"Grater","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Ware","sequence":"additional","affiliation":[{"name":"Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1026-8388","authenticated-orcid":false,"given":"Lawrence","family":"Devoe","sequence":"additional","affiliation":[{"name":"Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Schlabritz-Lutsevich","sequence":"additional","affiliation":[{"name":"Advanced Fertility Institute, Texas Tech University Health Sciences Center, Permian Basin, Odessa, TX 79762, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"David","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Toussaint","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6226-4082","authenticated-orcid":false,"given":"James","family":"Maher","sequence":"additional","affiliation":[{"name":"Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta, GA 30912, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"137.e1","DOI":"10.1016\/j.ajog.2012.05.021","article-title":"Non-Invasive Chromosomal Evaluation (NICE) Study: Results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18","volume":"207","author":"Norton","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/pd.4100","article-title":"Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease","volume":"33","author":"Osborne","year":"2013","journal-title":"Prenat. Diagn."},{"key":"ref_4","first-page":"9936936","article-title":"Phenotype-Genotype Discordance and a Case of a Disorder of Sexual Differentiation","volume":"2024","author":"Snipes","year":"2024","journal-title":"Case Rep. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/s41436-021-01205-x","article-title":"Privacy practices using genetic data from cell-free DNA aneuploidy screening","volume":"23","author":"Parobek","year":"2021","journal-title":"Genet. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/AOG.0000000000004833","article-title":"Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening","volume":"140","author":"Rink","year":"2022","journal-title":"Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"374.e1","DOI":"10.1016\/j.ajog.2012.08.033","article-title":"Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population","volume":"207","author":"Nicolaides","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/uog.14792","article-title":"Non-invasive prenatal testing for trisomies 21, 18 and 13: Clinical experience from 146,958 pregnancies","volume":"45","author":"Zhang","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pd.2730","article-title":"Aneuploidy screening: A position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011","volume":"31","author":"Benn","year":"2011","journal-title":"Prenat. Diagn."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2015.7120","article-title":"Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies","volume":"314","author":"Bianchi","year":"2015","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa2401029","article-title":"Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer","volume":"391","author":"Turriff","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM196605262742104","article-title":"Predictive value of a single diagnostic test in unselected populations","volume":"274","author":"Vecchio","year":"1966","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Paluoja, P., Teder, H., Ardeshirdavani, A., Bayindir, B., Vermeesch, J., Salumets, A., Krjut\u0161kov, K., and Palta, P. (2021). Systematic evaluation of NIPT aneuploidy detection software tools with clinically validated NIPT samples. PLoS Comput. Biol., 17.","DOI":"10.1101\/2021.05.27.445941"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhen, J., Zhang, L., Wang, H., Chen, X., Wang, W., Li, L., and Zhang, Q. (2025). Clinical experience of genome-wide non-invasive prenatal testing as a first-tier screening test in a cohort of 59,771 pregnancies. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0329463"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.gim.2022.03.019","article-title":"Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies","volume":"24","author":"Rose","year":"2022","journal-title":"Genet. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/gim.2013.26","article-title":"Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism","volume":"15","author":"Hall","year":"2013","journal-title":"Genet. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/pd.5049","article-title":"Discordant non-invasive prenatal testing (NIPT)\u2014A systematic review","volume":"37","author":"Hartwig","year":"2017","journal-title":"Prenat. Diagn."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0140-6736(22)02610-1","article-title":"Cell-free fetal DNA for genetic evaluation in Copenhagen Pregnancy Loss Study (COPL): A prospective cohort study","volume":"401","author":"Ambye","year":"2023","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ajog.2019.01.009","article-title":"Expanding the indications for cell-free DNA in the maternal circulation: Clinical considerations and implications","volume":"220","author":"Bartha","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1056\/NEJMra1705345","article-title":"Sequencing of Circulating Cell-free DNA during Pregnancy","volume":"379","author":"Bianchi","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/pd.6158","article-title":"Discordant cfDNA-NIPT result unraveling a trisomy 12 chronic lymphocytic leukemia in a 37 years old pregnant woman","volume":"42","author":"Bottillo","year":"2022","journal-title":"Prenat. Diagn."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"61ra91","DOI":"10.1126\/scitranslmed.3001720","article-title":"Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus","volume":"2","author":"Lo","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Eltabbakh, N., Mohasin, Y., and Jeddy, R. (2024). Advancements of non-invasive prenatal testing: The role of obstetricians. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1388481"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ajog.2023.11.1240","article-title":"Placental, maternal, fetal, and technical origins of false-positive cell-free DNA screening results","volume":"230","author":"Raymond","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40246-019-0244-0","article-title":"Factors affecting cell-free DNA fetal fraction: Statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening","volume":"13","author":"Hou","year":"2019","journal-title":"Hum. Genom."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tjog.2019.11.003","article-title":"Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review","volume":"59","author":"Samura","year":"2020","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Feresin, A., Stampalija, T., Cappellani, S., Bussani, R., Faletra, F., Murru, F., Ulivi, S., Suergiu, S., Savarese, P., and Pedicini, A. (2022). Case Report: Two cases of apparent discordance between non-invasive prenatal testing (NIPT) and amniocentesis resulting in feto-placental mosaicism of trisomy 21. Issues in diagnosis, investigation and counselling. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.982508"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: Updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/uog.23763","article-title":"Influence of fibroids on cell-free DNA screening accuracy","volume":"59","author":"Scott","year":"2022","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bpobgyn.2017.02.004","article-title":"Chromosomal mosaicism in the fetoplacental unit","volume":"42","author":"Grati","year":"2017","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/pd.5863","article-title":"Impact of mosaicism ratio on positive predictive value of cfDNA screening","volume":"41","author":"Rafalko","year":"2021","journal-title":"Prenat. Diagn."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJMc1509813","article-title":"Copy-Number Variation and False Positive Prenatal Screening Results","volume":"375","author":"Chudova","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.ajhg.2022.04.018","article-title":"Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study","volume":"109","author":"Sistermans","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/clinchem\/hvaf076","article-title":"Assessment of Placental Chromosomal Mosaicism during Prenatal Cell-Free DNA Screening Refines Positive Predictive Values for Fetal Trisomy","volume":"71","author":"Flowers","year":"2025","journal-title":"Clin. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1097-0223(199703)17:3<201::AID-PD56>3.0.CO;2-H","article-title":"Rare trisomy mosaicism diagnosed in amniocytes, involving an autosome other than chromosomes 13, 18, 20, and 21: Karyotype\/phenotype correlations","volume":"17","author":"Hsu","year":"1997","journal-title":"Prenat. Diagn."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"eaan1240","DOI":"10.1126\/scitranslmed.aan1240","article-title":"Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease","volume":"9","author":"Pertile","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"100336","DOI":"10.1016\/j.gim.2022.11.004","article-title":"Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Dungan","year":"2023","journal-title":"Genet. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kaseniit, K.E., Hogan, G.J., D\u2019Auria, K.M., Haverty, C., and Muzzey, D. (2018). Strategies to minimize false positives and interpret novel microdeletions based on maternal copy-number variants in 87,000 noninvasive prenatal screens. BMC Med. Genom., 11.","DOI":"10.1186\/s12920-018-0410-6"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/uog.26272","article-title":"Late first-trimester ultrasound findings can alter management after high-risk NIPT result","volume":"62","author":"Scott","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ajog.2022.08.034","article-title":"The predictive value of prenatal cell-free DNA testing for rare autosomal trisomies: A systematic review and meta-analysis","volume":"228","author":"Acreman","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ceb.2006.10.002","article-title":"Does aneuploidy cause cancer?","volume":"18","author":"Weaver","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10238-024-01313-3","article-title":"Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies","volume":"24","author":"Giudice","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0140-6736(23)01700-2","article-title":"Blood-based tests for multicancer early detection (PATHFINDER): A prospective cohort study","volume":"402","author":"Schrag","year":"2023","journal-title":"Lancet"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/OP.23.00594","article-title":"Comprehensive Recommendations for the Clinical Management of Pregnant Women With Noninvasive Prenatal Test Results Suspicious of a Maternal Malignancy","volume":"20","author":"Heesterbeek","year":"2024","journal-title":"JCO Oncol. Pract."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.21.02260","article-title":"Noninvasive Prenatal Test Results Indicative of Maternal Malignancies: A Nationwide Genetic and Clinical Follow-Up Study","volume":"40","author":"Heesterbeek","year":"2022","journal-title":"J. Clin. Oncol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/10\/1490\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:21:02Z","timestamp":1778764862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/10\/1490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["diagnostics16101490"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16101490","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}